Cornercap Investment Counsel’s Allergan plc AGN Stock Holding History

Cornercap Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,260	Closed	-$241K	–	715
2020 Q4	$241K	Buy	+1,260	New	+$241K	0.03%	404
2020 Q2	–	Sell	-1,260	Closed	-$223K	–	483
2020 Q1	$223K	Hold	1,260	–	–	0.04%	377
2019 Q4	$241K	Sell	1,260 -94	-7%	-$17K	0.03%	383
2019 Q3	$228K	Sell	1,354 -14,919	-92%	-$2.43M	0.03%	379
2019 Q2	$2.73M	Buy	16,273 +6,200	+62%	+$859K	0.36%	93
2019 Q1	$1.48M	Buy	+10,073	New	+$1.46M	0.2%	152

Other funds holding AGN

ABC

Associated Banc-Corp Green Bay, Wisconsin $4.21B AUM 27.98% 1-Year Est. Return

Cornercap Investment Counsel's AGN Position: Q1 2021 in Review

Cornercap Investment Counsel sold out of Allergan plc (AGN) in Q1 2021, closing a stake of 1,260 shares — an estimated $241K sold.

Cornercap Investment Counsel first reported a position in AGN in Q1 2019 and held it in 6 quarters. The position peaked at $2.73M in Q2 2019. 2 funds tracked by Wall St. Rank hold AGN as of Q1 2021.

Cornercap Investment Counsel reported no remaining Allergan plc position as of Q1 2021 after selling out during the quarter.
Cornercap Investment Counsel sold 1,260 Allergan plc shares in Q1 2021, an estimated $241K.
Cornercap Investment Counsel first reported a position in Allergan plc in Q1 2019 and held it in 6 quarters.
Cornercap Investment Counsel's Allergan plc position peaked at $2.73M in Q2 2019.
2 funds tracked by Wall St. Rank held Allergan plc as of Q1 2021.

Based on Cornercap Investment Counsel's 13F filing for Q1 2021, filed 13 May 2021.